PPARGC1A and fatty liver disease: The expression of PPARG coactivator 1 alpha (Ppargc1a), which is involved in glucose and fatty acid metabolism, and cell death-inducing DFFA-like effector c (Fsp27), a lipid droplet protein involved in hepatic steatosis, were also significantly reduced (Fig. 7c).